Nuchem Therapeutics Inc.
Records under this name other than patents Nuchem Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Nuchem Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,428,425 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,884,675 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 11,912,711 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,608,344 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · High confidence | In force | High confidence |